Intravenous Zoledronate for a Patient with Paget's Disease
Journal of Bone Metabolism
;
: 223-226, 2014.
Article
in English
| WPRIM
| ID: wpr-86726
ABSTRACT
Paget's disease (PD) of bone is characterized by increase of bone resorption by atypical osteoclasts, followed by rapid new bone formation resulting in a disorganized mosaic bone. Although the pathophysiology is not fully understood, bisphosphonate, which is a potent anti-resorptive agent for treatment of osteoporosis, have been the most effective agents available for the treatment of PD. We report a case of PD of bone in a 49-year-old woman patient, who was treated with intravenous zoledronate.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Osteitis Deformans
/
Osteoclasts
/
Osteogenesis
/
Osteoporosis
/
Bone Resorption
/
Diphosphonates
/
Bone Density Conservation Agents
Limits:
Female
/
Humans
Language:
English
Journal:
Journal of Bone Metabolism
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS